Citigroup Cuts H. B. Fuller (NYSE:FUL) Price Target to $63.00

H. B. Fuller (NYSE:FUL) had its target price cut by stock analysts at Citigroup from $75.00 to $63.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the specialty chemicals company’s stock. Citigroup’s price target would indicate a potential upside of 29.00% from the stock’s current price.

FUL has been the topic of a number of other research reports. Zacks Research lowered H. B. Fuller from a “strong-buy” rating to a “hold” rating in a research report on Friday, September 18th. Robert W. Baird reduced their price target on H. B. Fuller from $75.00 to $65.00 and set an “outperform” rating for the company in a research report on Friday. Weiss Ratings cut shares of H. B. Fuller from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, September 14th. UBS Group set a $69.00 price objective on shares of H. B. Fuller in a report on Friday, June 26th. Finally, Raymond James Financial set a $67.00 price objective on shares of H. B. Fuller in a research report on Friday, June 26th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $66.00.

H. B. Fuller Stock Down 2.4%

FUL stock traded down $1.22 during trading hours on Monday, reaching $48.84. 114,455 shares of the stock were exchanged, compared to its average volume of 662,683. The firm’s 50-day moving average is $55.71 and its 200-day moving average is $58.37. The company has a market cap of $2.63 billion, a price-to-earnings ratio of 13.63, a PEG ratio of 0.55 and a beta of 0.97. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.82 and a quick ratio of 1.10. H. B. Fuller has a 12 month low of $46.70 and a 12 month high of $68.63.

H. B. Fuller (NYSE:FUL) last issued its quarterly earnings results on Thursday, September 24th. The specialty chemicals company reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.05. The company had revenue of $938.17 million for the quarter, compared to analyst estimates of $945.59 million. H. B. Fuller had a return on equity of 12.65% and a net margin of 5.56%.The company’s quarterly revenue was up 5.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.26 earnings per share. On average, equities research analysts expect that H. B. Fuller will post 4.78 earnings per share for the current year.

Insider Transactions at H. B. Fuller

In related news, VP Nathan Weaver sold 9,561 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $62.06, for a total value of $593,355.66. Following the completion of the sale, the vice president directly owned 11,739 shares in the company, valued at approximately $728,522.34. This trade represents a 44.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.83% of the company’s stock.

Hedge Funds Weigh In On H. B. Fuller

A number of institutional investors have recently bought and sold shares of the business. Hantz Financial Services Inc. raised its stake in H. B. Fuller by 432.9% in the fourth quarter. Hantz Financial Services Inc. now owns 778 shares of the specialty chemicals company’s stock valued at $46,000 after buying an additional 632 shares during the period. Parallel Advisors LLC boosted its stake in shares of H. B. Fuller by 85.6% during the 1st quarter. Parallel Advisors LLC now owns 1,034 shares of the specialty chemicals company’s stock worth $64,000 after acquiring an additional 477 shares during the period. Public Employees Retirement System of Ohio acquired a new position in shares of H. B. Fuller during the 2nd quarter worth approximately $86,000. Caitong International Asset Management Co. Ltd increased its holdings in shares of H. B. Fuller by 510.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,466 shares of the specialty chemicals company’s stock worth $87,000 after acquiring an additional 1,226 shares during the last quarter. Finally, Bayban bought a new stake in H. B. Fuller in the 4th quarter valued at $156,000. Institutional investors and hedge funds own 95.93% of the company’s stock.

About H. B. Fuller

H.B. Fuller Company (NYSE: FUL) develops and manufactures specialty adhesives, sealants and other chemical-based products used in industrial and commercial applications. Its solutions help customers bond, seal, coat and assemble materials across a range of products and manufacturing processes.

The company serves markets including packaging, hygiene and disposable products, construction, transportation, electronics, durable assembly, woodworking, flooring, composites and renewable energy.